Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Administration, Inhalation"" wg kryterium: Temat


Tytuł:
Clinical evaluation of nebulized verapamil in out-patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Autorzy:
Fahimi F; American Career College, Anaheim, USA.
Pourdowlat G; Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Behzadnia N; Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mostofi SS; Clinical Pharmacy Department, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Forough AS; School of Clinical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane, Australia.
Parto O; Concorde Career College, Garden Grove, California, USA.
Esmaeili A; Experimental and Applied Pharmaceutical Sciences Research Center, Urmia University of Medical Sciences, Urmia, Iran.; Department of Clinical Pharmacy, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2022 Dec; Vol. 16 (12), pp. 802-811. Date of Electronic Publication: 2022 Nov 06.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Hypertension, Pulmonary*/drug therapy
Hypertension, Pulmonary*/etiology
Pulmonary Disease, Chronic Obstructive*/complications
Pulmonary Disease, Chronic Obstructive*/drug therapy
Humans ; Forced Expiratory Volume ; Verapamil ; Outpatients ; Administration, Inhalation ; Double-Blind Method
Czasopismo naukowe
Tytuł:
Preface: The engineering behind a dry powder inhaler: From experiments to computations.
Autorzy:
Kourmatzis A; School of Aerospace, Mechanical and Mechatronic Engineering, The University of Sydney, NSW 2006, Australia. Electronic address: .
Finlay WH; Department of Mechanical Engineering, University of Alberta, Edmonton, Alberta T6G 1H9, Canada.
Pokaż więcej
Źródło:
Advanced drug delivery reviews [Adv Drug Deliv Rev] 2022 Dec; Vol. 191, pp. 114593. Date of Electronic Publication: 2022 Nov 01.
Typ publikacji:
Editorial
MeSH Terms:
Dry Powder Inhalers*
Humans ; Administration, Inhalation ; Powders
Opinia redakcyjna
Tytuł:
Overprescription of short-acting β 2 -agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort study.
Autorzy:
Al-Jahdali H; Department of Pulmonology, King Saud University for Health Sciences, College of Medicine, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia.; King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Kingdom of Saudi Arabia.
Wali S; Pulmonology Division, King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia.
Albanna AS; King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Kingdom of Saudi Arabia.
Al Harbi A; Department of Pulmonology, King Fahad General Hospital, Medina, Kingdom of Saudi Arabia.
Allehebi R; Department of Pulmonology, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.; College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
Arwadi A; Department of Pulmonology, Specialized Medical Center Hospital, Riyadh, Kingdom of Saudi Arabia.
Dahan T; Department of Pulmonology, King Fahad Specialist Hospital, Dammam, Kingdom of Saudi Arabia.
Fattouh M; AstraZeneca GCC, Jeddah, Kingdom of Saudi Arabia.
Hamza E; AstraZeneca GCC, Jeddah, Kingdom of Saudi Arabia.
Beekman M; AstraZeneca, The Hague, The Netherlands.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2022 Dec; Vol. 16 (12), pp. 812-825. Date of Electronic Publication: 2022 Oct 24.
Typ publikacji:
Journal Article
MeSH Terms:
Asthma*/drug therapy
Asthma*/epidemiology
Anti-Asthmatic Agents*/therapeutic use
Humans ; Female ; Middle Aged ; Cohort Studies ; Cross-Sectional Studies ; Saudi Arabia/epidemiology ; Administration, Inhalation
Czasopismo naukowe
Tytuł:
Smart dry powder inhalers and intelligent adherence management.
Autorzy:
Häußermann S; VisionHealth GmbH, Munich, Germany. Electronic address: .
Arendsen LJ; VisionHealth GmbH, Munich, Germany.
Pritchard JN; Inspiring Strategies, Leicester, UK.
Pokaż więcej
Źródło:
Advanced drug delivery reviews [Adv Drug Deliv Rev] 2022 Dec; Vol. 191, pp. 114580. Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pulmonary Disease, Chronic Obstructive*/drug therapy
Asthma*/drug therapy
Humans ; Dry Powder Inhalers ; Administration, Inhalation
Czasopismo naukowe
Tytuł:
The Prescribing Practice for COPD: Relationship to Circadian Rhythm, Disease Severity, and Clinical Phenotype in the STORICO Observational Study.
Autorzy:
Incalzi RA; University Biomedical Campus of Rome, Via Alvaro del Portillo, 21, 00128, Rome, Italy. .
Blasi F; Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Via Francesco Sforza, 35, 20122, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza, 35, 20122, Milan, Italy.
Canonica GW; Personalized Medicine Asthma and Allergy Clinic, Humanitas University Humanitas Research Hospital Rozzano (Milan), Via Manzoni, 56, 20089, Rozzano (Milan), Italy.
Foschino MP; MAR4 Univ., D'Avanzo Hospital, Viale degli Aviatori, 1, 71122, Foggia, Italy.
Prediletto R; Pneumology, Institute of Clinical Physiology, National Research Council of Italy and Toscana G. Monasterio Foundation, Via Giuseppe Moruzzi, 1, 56124, Pisa, Italy.
Simoni L; Medineos Observational Research, Viale Virgilio 54/U, 41123, Modena, Italy.
Ori A; Medineos Observational Research, Viale Virgilio 54/U, 41123, Modena, Italy.
Giovannetti C; Laboratori Guidotti, Via Livornese, 897, 56122, Pisa, Italy.
Barsanti S; Laboratori Guidotti, Via Livornese, 897, 56122, Pisa, Italy.
Scichilone N; DIBIMIS, University of Palermo, Piazza delle Cliniche, 2, 90127, Palermo, Italy.
Pokaż więcej
Źródło:
Advances in therapy [Adv Ther] 2022 Dec; Vol. 39 (12), pp. 5582-5589. Date of Electronic Publication: 2022 Oct 11.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Adrenergic beta-2 Receptor Agonists*/therapeutic use
Pulmonary Disease, Chronic Obstructive*
Humans ; Circadian Rhythm ; Muscarinic Antagonists/therapeutic use ; Severity of Illness Index ; Phenotype ; Administration, Inhalation ; Bronchodilator Agents/therapeutic use ; Adrenal Cortex Hormones/therapeutic use ; Drug Therapy, Combination
Czasopismo naukowe
Tytuł:
Effects of rescue inhaled nitric oxide on right ventricle and pulmonary circulation in severe COVID-related acute respiratory distress syndrome.
Autorzy:
Bonizzoli M; Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. Electronic address: .
Lazzeri C; Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Cianchi G; Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Guetti C; Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Fulceri GE; Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Socci F; Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Peris A; Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Pokaż więcej
Źródło:
Journal of critical care [J Crit Care] 2022 Dec; Vol. 72, pp. 153987. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/complications
Respiratory Distress Syndrome*/drug therapy
Humans ; Pulmonary Circulation ; Nitric Oxide ; Heart Ventricles/diagnostic imaging ; RNA, Viral ; Administration, Inhalation ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Local variation in low carbon footprint inhalers in pre-COVID pandemic primary care prescribing guidelines for adult asthma in England and its potential impact.
Autorzy:
Twigg AJ; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wilkinson A; Respiratory Department, East and North Hertfordshire NHS Trust, Stevenage, UK.
Smith JN; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Dec; Vol. 88 (12), pp. 5083-5092. Date of Electronic Publication: 2022 Sep 07.
Typ publikacji:
Review; Journal Article
MeSH Terms:
COVID-19*/drug therapy
COVID-19*/epidemiology
Asthma*/drug therapy
Humans ; Adult ; Carbon Footprint ; Administration, Inhalation ; Pandemics ; Metered Dose Inhalers ; Dry Powder Inhalers ; Adrenal Cortex Hormones ; Primary Health Care
Czasopismo naukowe
Tytuł:
Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques.
Autorzy:
Xu F; CanSino Biologics, Tianjin, People's Republic of China.
Wu S; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People's Republic of China.
Yi L; CanSino Biologics, Tianjin, People's Republic of China.
Peng S; CanSino Biologics, Tianjin, People's Republic of China.
Wang F; CanSino Biologics, Tianjin, People's Republic of China.
Si W; CanSino Biologics, Tianjin, People's Republic of China.
Hou L; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People's Republic of China.
Zhu T; CanSino Biologics, Tianjin, People's Republic of China.
Pokaż więcej
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 438-441.
Typ publikacji:
Letter
MeSH Terms:
Immunity, Mucosal*
Adenoviridae/*immunology
COVID-19/*immunology
COVID-19 Vaccines/*immunology
Genetic Vectors/*immunology
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Adenoviridae/genetics ; Administration, Inhalation ; Animals ; COVID-19/prevention & control ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/genetics ; Disease Models, Animal ; Genetic Vectors/genetics ; Humans ; Immunogenicity, Vaccine ; Macaca mulatta ; SARS-CoV-2/genetics ; Spike Glycoprotein, Coronavirus/administration & dosage ; Spike Glycoprotein, Coronavirus/genetics
Opinia redakcyjna
Tytuł:
SABA prescriptions and asthma management practices in patients treated by specialists in Taiwan: Results from the SABINA III study.
Autorzy:
Shen SY; Mackay Memorial Hospital, Taipei, Taiwan.
Chen CW; National Cheng Kung University Hospital, Tainan, Taiwan.
Liu TC; Cheng Ching Hospital Chung Kang Branch, Taichung, Taiwan.
Wang CY; Cardinal Tien Hospital, New Taipei City, Taiwan.
Chiu MH; Cathay General Hospital, Taipei, Taiwan.
Chen YJ; Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan.
Lan CC; Taipei Tzu Chi Hospital, New Taipei City, Taiwan.
Shieh JM; Chi Mei Medical Center, Tainan, Taiwan.
Lin CM; Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Wu SH; Taipei City Hospital Zhongxiao Branch, Taipei, Taiwan.
Wang HC; National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Yang L; AstraZeneca, Singapore, Singapore.
Beekman MJ; AstraZeneca, The Hague, the Netherlands.
Pokaż więcej
Źródło:
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2022 Dec; Vol. 121 (12), pp. 2527-2537. Date of Electronic Publication: 2022 Jun 17.
Typ publikacji:
Journal Article
MeSH Terms:
Asthma*/drug therapy
Humans ; Female ; Middle Aged ; Administration, Inhalation ; Cross-Sectional Studies ; Taiwan ; Adrenal Cortex Hormones/therapeutic use ; Prescriptions
Czasopismo naukowe
Tytuł:
In vitro evaluation of the inhalation toxicity of the cosmetic ingredient aluminum chlorohydrate.
Autorzy:
Thá EL; Graduate Program in Genetics, Department of Genetics-Federal University of Paraná (UFPR), Curitiba, Brazil.
Gagosian VSC; Graduate Program in Genetics, Department of Genetics-Federal University of Paraná (UFPR), Curitiba, Brazil.
Canavez ADPM; Product Safety Management-Q&PP, Grupo Boticário, São José dos Pinhais, Brazil.
Schuck DC; Product Safety Management-Q&PP, Grupo Boticário, São José dos Pinhais, Brazil.
Brohem CA; Product Safety Management-Q&PP, Grupo Boticário, São José dos Pinhais, Brazil.
Gradia DF; Department of Genetics, Federal University of Paraná (UFPR), Curitiba, Brazil.
de Freitas RA; BioPol, Chemistry Department, Federal University of Paraná (UFPR), Curitiba, Brazil.
Prado KB; Department of Genetics, Federal University of Paraná (UFPR), Curitiba, Brazil.
Cestari MM; Department of Genetics, Federal University of Paraná (UFPR), Curitiba, Brazil.
Lorencini M; Product Safety Management-Q&PP, Grupo Boticário, São José dos Pinhais, Brazil.
Leme DM; Department of Genetics, Federal University of Paraná (UFPR), Curitiba, Brazil.
Pokaż więcej
Źródło:
Journal of applied toxicology : JAT [J Appl Toxicol] 2022 Dec; Vol. 42 (12), pp. 2016-2029. Date of Electronic Publication: 2022 Aug 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Aluminum*
Cosmetics*
Humans ; Administration, Inhalation ; Aerosols ; Pharmaceutical Vehicles ; Inhalation Exposure/adverse effects
Czasopismo naukowe
Tytuł:
A review of upper airway physiology relevant to the delivery and deposition of inhalation aerosols.
Autorzy:
Mekonnen T; School of Engineering, Faculty of Science and Engineering, Macquarie University, Australia.
Cai X; School of Engineering, Faculty of Science and Engineering, Macquarie University, Australia.
Burchell C; School of Engineering, Faculty of Science and Engineering, Macquarie University, Australia.
Gholizadeh H; School of Engineering, Faculty of Science and Engineering, Macquarie University, Australia.
Cheng S; School of Engineering, Faculty of Science and Engineering, Macquarie University, Australia. Electronic address: .
Pokaż więcej
Źródło:
Advanced drug delivery reviews [Adv Drug Deliv Rev] 2022 Dec; Vol. 191, pp. 114530. Date of Electronic Publication: 2022 Sep 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pulmonary Disease, Chronic Obstructive*/drug therapy
Asthma*/drug therapy
Humans ; Respiratory Aerosols and Droplets ; Administration, Inhalation ; Respiratory System
Czasopismo naukowe
Tytuł:
Nanocrystals based pulmonary inhalation delivery system: advance and challenge.
Autorzy:
Yue P; Key Lab of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, People's Republic of China.
Zhou W; Key Lab of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, People's Republic of China.
Huang G; Key Lab of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, People's Republic of China.
Lei F; Key Lab of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, People's Republic of China.
Chen Y; Key Lab of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, People's Republic of China.
Ma Z; Langka Biotechnology (Shanghai) Co., Ltd, Shanghai, People's Republic of China.
Chen L; Beijing Hospital, Beijing, People's Republic of China.
Yang M; Key Lab of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, People's Republic of China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 637-651.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Drug Carriers/*pharmacokinetics
Lung/*drug effects
Lung/*metabolism
Administration, Inhalation ; Cell Survival/drug effects ; Chemistry, Pharmaceutical/methods ; Drug Carriers/chemistry ; Drug Liberation ; Drug Stability ; Freeze Drying/methods ; Macrophages, Alveolar/metabolism ; Nanoparticles/chemistry ; Particle Size ; Pulmonary Surfactants/pharmacology ; Solubility ; Technology, Pharmaceutical/methods
Czasopismo naukowe
Tytuł:
Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality.
Autorzy:
Suissa S; Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, Canada.; Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada.
Dell'Aniello S; Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, Canada.; Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada.
Ernst P; Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, Canada.; Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada.
Pokaż więcej
Źródło:
COPD [COPD] 2022 Dec; Vol. 19 (1), pp. 1-9. Date of Electronic Publication: 2021 Sep 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pneumonia*/etiology
Pulmonary Disease, Chronic Obstructive*
Administration, Inhalation ; Adrenal Cortex Hormones/therapeutic use ; Adrenergic beta-2 Receptor Agonists/therapeutic use ; Bronchodilator Agents/therapeutic use ; Drug Therapy, Combination ; Humans ; Middle Aged ; Muscarinic Antagonists ; Nebulizers and Vaporizers
Czasopismo naukowe
Tytuł:
Engineering the right formulation for enhanced drug delivery.
Autorzy:
Ke WR; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Chang RYK; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW 2006, Australia.
Chan HK; Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW 2006, Australia.
Pokaż więcej
Źródło:
Advanced drug delivery reviews [Adv Drug Deliv Rev] 2022 Dec; Vol. 191, pp. 114561. Date of Electronic Publication: 2022 Oct 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lactose*/chemistry
Biological Products*
Humans ; Powders/chemistry ; Administration, Inhalation ; Chemistry, Pharmaceutical ; Dry Powder Inhalers/methods ; Pharmaceutical Preparations/chemistry ; Particle Size ; Aerosols/chemistry
Czasopismo naukowe
Tytuł:
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.
Autorzy:
Thompson PJ; The Lung Health Clinic, Nedlands, Western Australia, Australia.
Criner GJ; Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
Dransfield MT; Division of Pulmonary, Allergy, and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Halpin DMG; University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
Han MK; Pulmonary & Critical Care, University of Michigan, Ann Arbor, Michigan, USA.
Lipson DA; GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Maghzal GJ; GSK, Melbourne, Victoria, Australia.
Martinez FJ; Weill Cornell Medicine, New York, New York, USA.
Midwinter D; GSK, Brentford, UK.
Singh D; Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester University NHS Foundation Hospital Trust, Manchester, UK.
Tombs L; Precise Approach Limited, London, UK.
Wise RA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Respirology (Carlton, Vic.) [Respirology] 2022 Dec; Vol. 27 (12), pp. 1034-1044. Date of Electronic Publication: 2022 Aug 15.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Bronchodilator Agents*
Pulmonary Disease, Chronic Obstructive*/drug therapy
Humans ; Administration, Inhalation ; Forced Expiratory Volume ; Fluticasone ; Double-Blind Method ; Mucus ; Drug Combinations ; Treatment Outcome ; Androstadienes/therapeutic use ; Androstadienes/adverse effects
Czasopismo naukowe
Tytuł:
Derivation of asthma severity from electronic prescription records using British thoracic society treatment steps.
Autorzy:
Tibble H; Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK. .; Asthma UK Centre for Applied Research, Edinburgh, UK. .; Usher Institute, NINE Bioquarter, University of Edinburgh, 9 Little France road, EH16 4UX, Edinburgh, France. .
Sheikh A; Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.; Asthma UK Centre for Applied Research, Edinburgh, UK.; Health Data Research UK BREATHE Hub for Respiratory Health, University of Edinburgh, Edinburgh, UK.
Tsanas A; Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.; Asthma UK Centre for Applied Research, Edinburgh, UK.; The Alan Turing Institute, London, UK.
Pokaż więcej
Źródło:
BMC pulmonary medicine [BMC Pulm Med] 2022 Nov 03; Vol. 22 (1), pp. 397. Date of Electronic Publication: 2022 Nov 03.
Typ publikacji:
Journal Article
MeSH Terms:
Electronic Prescribing*
Asthma*/drug therapy
Asthma*/epidemiology
Anti-Asthmatic Agents*/therapeutic use
Adult ; Humans ; Administration, Inhalation ; Retrospective Studies ; Adrenal Cortex Hormones/therapeutic use ; Drug Therapy, Combination
Czasopismo naukowe
Tytuł:
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis.
Autorzy:
Lee B; Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.; Asthma UK Centre for Applied Research, University of Edinburgh, Edinburgh, UK.
Lewis G; Asthma UK Centre for Applied Research, University of Edinburgh, Edinburgh, UK.; School of Healthcare, University of Leeds, Leeds, UK.
Agyei-Manu E; Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.
Atkins N; Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.
Bhattacharyya U; Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.
Dozier M; Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.
Rostron J; Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.
Sheikh A; Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.; Asthma UK Centre for Applied Research, University of Edinburgh, Edinburgh, UK.
McQuillan R; Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK .; R. McQuillan and E. Theodoratou contributed equally to this article as lead authors and supervised the work.
Theodoratou E; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.; Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; R. McQuillan and E. Theodoratou contributed equally to this article as lead authors and supervised the work.
Pokaż więcej
Corporate Authors:
Usher Network for COVID-19 Evidence Reviews (UNCOVER) group
Źródło:
European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2022 Nov 02; Vol. 31 (166). Date of Electronic Publication: 2022 Nov 02 (Print Publication: 2022).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Anti-Asthmatic Agents*/adverse effects
COVID-19*
Asthma*/diagnosis
Asthma*/drug therapy
Asthma*/epidemiology
Adult ; Child ; Humans ; Administration, Inhalation ; Adrenal Cortex Hormones/therapeutic use
Czasopismo naukowe
Tytuł:
Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumilast into ceftazidime-leucine co-amorphous formulation.
Autorzy:
Raj Adhikari B; School of Pharmacy, University of Otago, Dunedin 9054, New Zealand.
Sinha S; School of Pharmacy, University of Otago, Dunedin 9054, New Zealand; Department of Microbiology and Immunology, Dunedin 9016, New Zealand.
Lyons N; Department of Microbiology and Immunology, Dunedin 9016, New Zealand.
Pletzer D; Department of Microbiology and Immunology, Dunedin 9016, New Zealand.
Lamont I; Department of Biochemistry, Dunedin 9016, New Zealand.
Gordon KC; The Dodd-Walls Centre for Photonic and Quantum Technologies, Department of Chemistry, University of Otago, Dunedin 9016, New Zealand.
Das SC; School of Pharmacy, University of Otago, Dunedin 9054, New Zealand. Electronic address: .
Pokaż więcej
Źródło:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2022 Nov; Vol. 180, pp. 260-268. Date of Electronic Publication: 2022 Oct 12.
Typ publikacji:
Journal Article
MeSH Terms:
Ceftazidime*
Dry Powder Inhalers*/methods
Humans ; Powders/chemistry ; Leucine/chemistry ; Particle Size ; Aerosols/chemistry ; Amino Acids/chemistry ; Inflammation ; Administration, Inhalation
Czasopismo naukowe
Tytuł:
Dual bronchodilator treatment for prevention of COPD in at-risk smokers.
Autorzy:
Thamrin C; Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Martin A; The George Institute for Global Health, Newtown, New South Wales, Australia.; UNSW Medicine & Health, University of New South Wales, Sydney, New South Wales, Australia.
Badal T; Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.; Department of Thoracic Medicine, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
Jeagal E; Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Cochrane B; Department of Respiratory and Sleep Medicine, Campbelltown Hospital, Campbelltown, New South Wales, Australia.; School of Medicine, Western Sydney University, Sydney, New South Wales, Australia.
Farah CS; Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Department of Thoracic Medicine, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
King GG; Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Department of Respiratory Medicine, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.
Nagarajah M; School of Medicine, Western Sydney University, Sydney, New South Wales, Australia.; Department of Respiratory and Sleep Medicine, Blacktown Hospital, Blacktown, New South Wales, Australia.
Li Q; The George Institute for Global Health, Newtown, New South Wales, Australia.; UNSW Medicine & Health, University of New South Wales, Sydney, New South Wales, Australia.
Liu X; The George Institute for Global Health, Newtown, New South Wales, Australia.
Berend N; Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Jenkins CR; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; The George Institute for Global Health, Newtown, New South Wales, Australia.; UNSW Medicine & Health, University of New South Wales, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
Respirology (Carlton, Vic.) [Respirology] 2022 Nov; Vol. 27 (11), pp. 983-986. Date of Electronic Publication: 2022 Sep 11.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Bronchodilator Agents*/therapeutic use
Pulmonary Disease, Chronic Obstructive*/drug therapy
Pulmonary Disease, Chronic Obstructive*/prevention & control
Administration, Inhalation ; Drug Combinations ; Humans ; Muscarinic Antagonists/therapeutic use ; Smokers ; Treatment Outcome
Raport
Tytuł:
The accuracy of ventilator logbooks in calculating environmental burden of inhalational agents.
Autorzy:
Gandhi J; Freeman Hospital, Newcastle Upon Tyne, UK.
Baxter I; Freeman Hospital, Newcastle Upon Tyne, UK.
Pokaż więcej
Źródło:
Anaesthesia [Anaesthesia] 2022 Nov; Vol. 77 (11), pp. 1304-1305. Date of Electronic Publication: 2022 Jul 28.
Typ publikacji:
Letter
MeSH Terms:
Ventilators, Mechanical*
Administration, Inhalation ; Data Collection ; Humans
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz